文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

院外心脏骤停后目标血压、氧合与设备降温时长的联合效应对1年生存的影响:一项随机对照试验的事后分析

Combined effects of targeted blood pressure, oxygenation, and duration of device-based fever prevention after out-of-hospital cardiac arrest on 1-year survival: post hoc analysis of a randomized controlled trial.
PubMed 文献 · Crit Care · 2024-01-12
一句话结论BOX试验事后分析显示,院外心脏骤停昏迷患者采用低或高目标血压、限制性或宽松氧合目标、36或72小时设备降温,1年死亡率均无差异。

该研究为BOX随机对照试验的事后分析,纳入789例院外心脏骤停后昏迷的复苏患者,同时随机分配至平均动脉压目标63 mmHg或77 mmHg、动脉氧合目标9-10 kPa或13-14 kPa、设备降温总时长36小时(36 °C 24小时+37 °C 12小时)或72小时(36 °C 24小时+37 °C 48小时)。1年全因死亡率在三组干预间均无显著差异:血压目标HR 0.92(0.73-1.16)p=0.47,氧合目标HR 0.92(0.73-1.16)p=0.46,降温时长HR 0.98(0.78-1.24)p=0.89。各干预之间无交互作用迹象,任何组合均未显示差异化治疗效果。

要点

  • 低目标血压(63 mmHg)与高目标血压(77 mmHg)相比,1年死亡率35%(138/396)vs 36%(143/393),HR 0.92(0.73-1.16)p=0.47。
  • 限制性氧合目标(9-10 kPa)与宽松目标(13-14 kPa)相比,1年死亡率34%(135/394)vs 37%(146/395),HR 0.92(0.73-1.16)p=0.46。
  • 设备降温36小时与72小时相比,1年死亡率35%(139/393)vs 36%(142/396),HR 0.98(0.78-1.24)p=0.89。
  • 三项干预之间无交互作用迹象,无任何随机化组合显示差异化治疗效果。

适用人群与场景

  • 院外心脏骤停后复苏成功并处于昏迷状态的患者,纳入BOX试验并随机分配至三项干预。

处置流程与药物剂量

  • 血压目标:平均动脉压63 mmHg或77 mmHg。
  • 氧合目标:动脉氧分压9-10 kPa或13-14 kPa。
  • 设备降温:初始24小时维持36 °C,随后12小时或48小时维持37 °C,总温度控制时长分别为36小时或72小时。
  • 三项干预同时平行随机化。

研究设计与关键结果

  • 研究类型:随机对照试验的事后分析,两中心,纳入789例院外心脏骤停后昏迷患者。
  • 低血压目标组(63 mmHg)1年死亡率35%(138/396)vs 高血压目标组(77 mmHg)36%(143/393),HR 0.92(0.73-1.16)p=0.47。
  • 限制性氧合目标组(9-10 kPa)1年死亡率34%(135/394)vs 宽松氧合目标组(13-14 kPa)37%(146/395),HR 0.92(0.73-1.16)p=0.46。
  • 设备降温36小时组1年死亡率35%(139/393)vs 72小时组36%(142/396),HR 0.98(0.78-1.24)p=0.89。
  • 三项干预之间无交互作用迹象,无任何随机化组合显示差异化治疗效果。

证据类型、等级与局限

  • 证据类型:随机对照试验的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于院外心脏骤停后昏迷患者,低或高目标血压、限制性或宽松氧合目标、36或72小时设备降温在1年死亡率上无差异,作者未据此给出特定推荐。

指南或共识出处

  • BOX试验(Blood Pressure and Oxygenation Targets in Post Resuscitation Care),ClinicalTrials.gov NCT03141099,注册日期2017年4月30日。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The "Blood Pressure and Oxygenation Targets in Post Resuscitation Care" (BOX) trial investigated whether a low versus high blood pressure target, a restrictive versus liberal oxygenation target, and a shorter versus longer duration of device-based fever prevention in comatose patients could improve outcomes. No differences in rates of discharge from hospital with severe disability or 90-day mortality were found. However, long-term effects and potential interaction of the interventions are unknown. Accordingly, the objective of this study is to investigate both individual and combined effects of the interventions on 1-year mortality rates.

METHODS: The BOX trial was a randomized controlled two-center trial that assigned comatose resuscitated out-of-hospital cardiac arrest patients to the following three interventions at admission: A blood pressure target of either 63 mmHg or 77 mmHg; An arterial oxygenation target of 9-10 kPa or 13-14 kPa; Device-based fever prevention administered as an initial 24 h at 36 °C and then either 12 or 48 h at 37 °C; totaling 36 or 72 h of temperature control. Randomization occurred in parallel and simultaneously to all interventions. Patients were followed for the occurrence of death from all causes for 1 year. Analyzes were performed by Cox proportional models, and assessment of interactions was performed with the interventions stated as an interaction term.

RESULTS: Analysis for all three interventions included 789 patients. For the intervention of low compared to high blood pressure targets, 1-year mortality rates were 35% (138 of 396) and 36% (143 of 393), respectively, hazard ratio (HR) 0.92 (0.73-1.16) p = 0.47. For the restrictive compared to liberal oxygenation targets, 1-year mortality rates were 34% (135 of 394) and 37% (146 of 395), respectively, HR 0.92 (0.73-1.16) p = 0.46. For device-based fever prevention for a total of 36 compared to 72 h, 1-year mortality rates were 35% (139 of 393) and 36% (142 of 396), respectively, HR 0.98 (0.78-1.24) p = 0.89. There was no sign of interaction between the interventions, and accordingly, no combination of randomizations indicated differentiated treatment effects.

CONCLUSIONS: There was no difference in 1-year mortality rates for a low compared to high blood pressure target, a liberal compared to restrictive oxygenation target, or a longer compared to shorter duration of device-based fever prevention after cardiac arrest. No combination of the interventions affected these findings. Trial registration ClinicalTrials.gov NCT03141099, Registered 30 April 2017.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Meyer MAS, Hassager C, Mølstrøm S, et al. Combined effects of targeted blood pressure, oxygenation, and duration of device-based fever prevention after out-of-hospital cardiac arrest on 1-year survival: post hoc analysis of a randomized controlled trial. Crit Care. 2024. PMID: 38216985. doi:10.1186/s13054-023-04794-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。